Q92831 (KAT2B_HUMAN) Homo sapiens (Human)
Histone acetyltransferase KAT2B UniProtKBInterProSTRINGInteractive Modelling
832 aa; Sequence (Fasta)
Available Structures
25 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| The Structural Basis for Site-Specific Lysine-Acetylated Histone Recognition by the Bromodomains of… |
Heteromer P61830; | 100 | ||||
| The Structural Basis for Site-Specific Lysine-Acetylated Histone Recognition by the Bromodomains of… |
Heteromer P61830; | 100 | ||||
| NMR Structure of P/CAF Bromodomain in Complex with HIV-1 Tat Peptide |
Heteromer P04610; | 100 | ||||
| Crystal structure of PCAF | homo-2-mer | 100.0 | 2×COA; | |||
| Crystal structure of human PCAF bromodomain in complex with compound-E (CPD-E) | homo-2-mer | 100 | 6×EDO; 1×78Y; 1×DMS; | |||
| Crystal structure of human PCAF bromodomain in complex with compound SL1122 (compound 13) | homo-2-mer | 100 | 2×5WS; 1×EDO; | |||
| Crystal structure of human PCAF bromodomain in complex with compound BDOMB00091a (compound 14) | homo-2-mer | 100 | 2×5X0; 2×EDO; | |||
| CRYSTAL STRUCTURE OF THE PCAF/COENZYME-A COMPLEX | monomer | 99.38 | 1×COA; | |||
| complex structure of PCAF bromodomain with small chemical ligand NP1 | monomer | 100 | 1×NP1; | |||
| Complex structure of PCAF bromodomain with small chemical ligand NP2 | monomer | 100 | 1×NP2; | |||
| Structure and Ligand of a Histone Acetyltransferase Bromodomain | monomer | 100 | ||||
| Structure-based evaluation of selective and non-selective small molecules that block HIV-1 TAT and … | monomer | 100 | 1×MIB; | |||
| Crystal structure of human PCAF bromodomain in complex with fragment ZB1916 (fragment 10) | monomer | 100 | 8×EDO; 1×5WZ; | |||
| Crystal structure of human PCAF bromodomain in complex with fragment ZB2216 (fragment 11) | monomer | 100 | 1×EDO; 1×5WU; | |||
| Crystal structure of human PCAF bromodomain in complex with fragment MB360 (fragment 4) | monomer | 100 | 3×EDO; 1×5WX; | |||
| Crystal structure of human PCAF bromodomain in complex with compound-D (CPD-D), N-methyl-2-(tetrahy… | monomer | 100 | 3×EDO; 1×2LX; | |||
| Crystal structure of human PCAF bromodomain in complex with compound SL1126 (compound 12) | monomer | 100 | 1×5WT; 4×EDO; | |||
| Crystal structure of human PCAF bromodomain in complex with fragment MB093 (fragment 7) | monomer | 100 | 5×EDO; 1×DMS; | |||
| Crystal structure of human PCAF bromodomain in complex with fragment MB364 (fragment 5) | monomer | 100 | 2×EDO; 1×5WY; | |||
| Crystal structure of human PCAF bromodomain in complex with fragment BR004 (fragment 1) | monomer | 100 | 1×12Q; | |||
| Crystal structure of human PCAF bromodomain in complex with acetyllysine | monomer | 100 | 1×ALY; | |||
| Crystal Structure of the Bromodomain of Human PCAF | monomer | 100 | 1×CL; | |||
| Crystal structure of human PCAF bromodomain in complex with fragment BR013 (fragment 3) | monomer | 100 | 1×5WV; 1×EDO; | |||
| 1.68A STRUCTURE PCAF BROMODOMAIN WITH 4-chloro-2-methyl-5-(methylamino)pyridazin-3(2H)-one | monomer | 100 | 1×82I; 1×SO4; 1×EPE; | |||
| Crystal structure of the human PCAF bromodomain in complex with compound 12 | monomer | 100 | 1×B4L; | |||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7by1.1.A | monomer | 0.79 | 2×ZN; | 70.74 | ||
| 6cw2.2.A | monomer | 0.68 | 49.78 | |||
| 1n72.1.A | monomer | 0.65 | 100.00 | |||